SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-21-013591
Filing Date
2021-05-27
Accepted
2021-05-27 20:48:34
Documents
1
Period of Report
2021-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 6002
  Complete submission text file 0001437749-21-013591.txt   7587
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Issuer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 712 VISTA BLVD, #305 WACONIA MN 55387
Business Address
Cullen Michael T. (Reporting) CIK: 0001652996 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39468 | Film No.: 21975443